Tests Designed For Developing World Could Benefit Established Markets, Too
This article was originally published in The Gray Sheet
Executive Summary
Test makers should view the developing world as a primary market feeding new technologies into more established economies, rather than the other way around, said speakers July 28-29 at the American Association of Clinical Chemistry annual meeting in Washington, D.C
You may also be interested in...
Market For Complex Genetic Tests Expands Beyond Specialized Labs
The market for sophisticated gene tests has the potential to greatly expand with the introduction of new "push-button" systems that require less expertise to operate
Nonprofit Foundation Engages Industry On TB Diagnostics Development
The Foundation for Innovative New Diagnostics is working with the diagnostics industry to create faster, more cost-effective tests for drug-resistant tuberculosis in developing countries
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.